OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma
Zhenpeng Zhu, Lanruo Lin, Tongde Lv, et al.
Oncology Reports (2020)
Open Access | Times Cited: 8
Zhenpeng Zhu, Lanruo Lin, Tongde Lv, et al.
Oncology Reports (2020)
Open Access | Times Cited: 8
Showing 8 citing articles:
Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma
Hongda Guo, Songlin Jiang, Haoyu Sun, et al.
Disease Markers (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 19
Hongda Guo, Songlin Jiang, Haoyu Sun, et al.
Disease Markers (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 19
Different Apples, Same Tree: Visualizing Current Biological and Clinical Insights into CTLA-4 Insufficiency and LRBA and DEF6 Deficiencies
Laura Gámez‐Díaz, Markus G. Seidel
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 14
Laura Gámez‐Díaz, Markus G. Seidel
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 14
A Novel Oncogenic Role of Disulfidptosis-related Gene SLC7A11 in Anti-tumor Immunotherapy Response to Human Cancers
Borui Xu, Jiahua Liang, Liangmin Fu, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 8, pp. 846-866
Closed Access | Times Cited: 1
Borui Xu, Jiahua Liang, Liangmin Fu, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 8, pp. 846-866
Closed Access | Times Cited: 1
A novel immune prognostic model of non-M3 acute myeloid leukemia.
Hong Ding, Yu Feng, Juan Xu, et al.
PubMed (2022) Vol. 14, Iss. 8, pp. 5308-5325
Closed Access | Times Cited: 4
Hong Ding, Yu Feng, Juan Xu, et al.
PubMed (2022) Vol. 14, Iss. 8, pp. 5308-5325
Closed Access | Times Cited: 4
Expression of PSTPIP1 in Renal cell carcinoma and its prognostic value
Yiyang Chen, Li Sun, Pu Zhang, et al.
(2024)
Closed Access
Yiyang Chen, Li Sun, Pu Zhang, et al.
(2024)
Closed Access
DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis
Ziming Yuan, Yuchen Zhong, Hanqing Hu, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 1
Ziming Yuan, Yuchen Zhong, Hanqing Hu, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 1
DEF6(differentially exprehomolog) exacerbates pathological cardiac hypertrophy via RAC1
Yan Sun, Zefeng Xu, Zhongxiu Jiang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 1
Yan Sun, Zefeng Xu, Zhongxiu Jiang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 1
Expression of PSTPIP1 in kidney renal clear cell carcinoma and its prognostic value
Li Sun, Zhenghong Liu, Xiaowen Qin, et al.
Research Square (Research Square) (2022)
Closed Access
Li Sun, Zhenghong Liu, Xiaowen Qin, et al.
Research Square (Research Square) (2022)
Closed Access
